| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Biotechnology (Health Care sector), XLO's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 325.4K | - | - | |
| Other | 33.3K | - | - | |
| CFO | 24.8K | $15.9K | - | |
| Dir | 10.0K | $87.9K | - | |
| VP | 6.4K | $4.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2024 | Atlas Venture Fund Xi, L.P.53 | 10% Owner | Sell | 4,235 | $0.85 | $3,600.45 | -0.6% | +83.0% | +48.0% | |
| Dec 10, 2021 | Bain Capital Life Sciences Investors, LLC48 | 10% Owner | Buy | 42,469 | $9.66 | $410,161.39 | +1.5% | -24.1% | -77.6% | |
| Oct 26, 2021 | Rivervest Venture Fund Iv, L.P. | 10% Owner | Buy | 250,000 | $16.00 | $4,000,000.00 | +21.0% | -12.5% | -86.4% | |
| Oct 26, 2021 | Atlas Venture Fund Xi, L.P.53 | 10% Owner | Buy | 187,500 | $16.00 | $3,000,000.00 | +34.2% | -12.5% | -86.4% | |
| Oct 26, 2021 | Rock Springs Capital Management LP | 10% Owner | Buy | 500,000 | $16.00 | $8,000,000.00 | +66.1% | -12.5% | -86.4% | |
| Oct 26, 2021 | Flynn James E62 | 10% Owner, Possible Member of 10% Group | Buy | 775,000 | $16.00 | $12,400,000.00 | +210.0% | -12.5% | -86.4% | |
| Oct 26, 2021 | Bay City Capital LLC | 10% Owner | Buy | 312,500 | $16.00 | $5,000,000.00 | +38.3% | -12.5% | -86.4% |